Although no GLP-1 therapy is currently approved for Parkinsons disease treatment, several studies are shaping important conversations about future therapeutic strategies
All authors have read and approved the final version of the manuscript and agree to be accountable for the work
International agencies can assist by standardizing data standards, trial design, and adverse-event reporting
Wegovy: Key differences The main difference between Saxenda and Wegovy is they contain different active ingredients
The findings make up Circanas new report Early Days of a Revolution: How GLP-1s Are Already Changing Consumer Spending
Your results depend on many factors your current health, any ongoing medical conditions, nutrition, activity level, and how closely you follow our program recommendations